Fundraising Fox
🦊/Companies
Sign in

Adiposs

2 known investors

Find your way into Adiposs

Adiposs develops ImageBAT, a contrast agent for medical imaging of brown fat that can identify patients at increased cancer risk and with higher treatment failure risk. The product serves oncology and metabolic health markets.

BiotechDigital HealthMedical Devices

Founders & leadership

DTDuc Tran
Duc TranChief Development Officer

Investors · 2

KickfundBasel · $950K
Privilège VenturesLugano · $100K – $1M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Adiposs raises CHF 4 million to advance imaging in cancer careggba.swiss · Jul 2025Medpathtrial.medpath.com · Jul 2025Adiposs SA Secures CHF 4 Million in Series A Funding to Advance First-in-Class Contrast Agent for Brown Fat into Proof-of-Principle Clinical Development - Adipossadiposs.com · Jun 2025Adiposs raises CHF 1.8M Pre-Series A Funding led by Privilège Ventures - Adipossadiposs.com · Jan 2022Adiposs raises CHF 1.8 million to start clinical trials and product industrializationventurelab.swiss · Jan 2022

Frequently asked questions

What does Adiposs do?
Adiposs develops ImageBAT, a contrast agent for medical imaging of brown fat that can identify patients at increased cancer risk and with higher treatment failure risk. The product serves oncology and metabolic health markets.
Who are Adiposs's investors?
Adiposs's investors include Kickfund, Privilège Ventures.